Cibus, Inc. Class A (CBUS) Dividend History

Company News

• Cibus, Inc. Announces Closing of $27.5 Million Public Offering

  Cibus, Inc., a leading agricultural biotechnology company, announced the closing of a $27.5 million public offering to fund further development of its weed management productivity traits in Rice and for working capital and general corporate purposes.

  GlobeNewswire Inc.
• Wall Street Breakfast: The Week Ahead

  Stay updated on Wall Street news with our daily podcast available on Seeking Alpha, iTunes, and Spotify.

  Seeking Alpha

  Featured Companies: ACN ADMA BFH CRMT DRI EBAY FDS GME IREN KBH KMX KR KROS LEN LZB MAXN MDB NNE NVRI ORA PAL PATH PSTG QGEN SVCO TRUP WMT
• Cibus (CBUS) Reports Q1 Loss, Tops Revenue Estimates

  Cibus (CBUS) delivered earnings and revenue surprises of -10.89% and 36.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: LVRO
• Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

  Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. Nuvve Holding Corp. (NASDAQ: NVVE) shares climbed 88% to $0.2789 after falling 10% on Tuesday. Nuvve recently announced pricing of a $1 million underwritten public offering of roughly 7 million shares of common stock at a price to the public of $0.14 per share. BIO-key International, Inc. (NASDAQ: BKYI) surged 57% to $0.30. BIO-key International reported results for its third quarter ended Sept. 30, 2023. ReShape Lifesciences Inc. (NASDAQ: RSLS) gained 44.7% to $0.2976 after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million public offering. BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares climbed 37.6% to $3.2199 after announcing positive findings from an independent third party audit of the data integrity at TRANQUILITY II Phase 3 trial site. ParaZero Technologies Ltd. (NASDAQ: PRZO) gained 26% to $2.0350. Catalyst Biosciences, Inc. (NASDAQ: CBIO) climbed 18% to $0.5095. Scholar Rock Holding Corporation (NASDAQ: SRRK) gained 16.5% to $8.92. Jefferies upgraded Scholar Rock from Hold to Buy and announced a $20 price target. Stride, Inc. (NYSE: LRN) rose 16.4% to $51.81 after the company reported first-quarter results. OncoCyte Corporation (NASDAQ: OCX) gained 14.4% to $2.86. Urgent.ly Inc. (NASDAQ: ULY) surged 14% to $5.01. GameSquare Holdings, Inc. (NASDAQ: GAME) gained 13.1% to $2.07. Treasure Global Inc. (NASDAQ: TGL) rose 12.8% to $0.4501. PROG Holdings, Inc. (NYSE: PRG) rose 9.3% to $31.14 following upbeat quarterly results. LumiraDx Limited (NASDAQ: LMDX) gained 8.4% to $0.1680 after dipping around 44% on Tuesday. John Bean Technologies Corporation (NYSE: JBT) surged 8.1% to $104.00 after posting strong quarterly earnings. Sonendo, Inc. (NYSE: SONX) shares gained 8% to $0.2483 after falling over 23% on Tuesday. Sonendo recently announced preliminary revenue results for the third quarter. Crown ElectroKinetics Corp. (NASDAQ: CRKN) climbed 8% to $0.2700. Deutsche Bank Aktiengesellschaft (NYSE: DB) rose 6.6% to $10.72 after the company reported a year-over-year increase in third-quarter EPS and sales results. Deutsche Bank Aktiengesellschaft (NYSE: DB) gained 6.6% to $10.72 after the company reported a year-over-year increase in third-quarter EPS and sales results. The Gap, Inc. (NYSE: GPS) climbed 6.2% ...

  Benzinga

  Featured Companies: ADP AFRM AIRE ALKS ASTI ATEC BIVI BKYI BOKF BTAI BYD CGTX CSGP CSTM DB DDD ENVA ERII GAME GBX GOOGL IDYA INM INTZ LEDS LIPO LRN LTH MKTX MPX MSFT NVVE OC OCX OPCH PRG PRZO RGEN RSLS SONN SPWR SRRK SSYS TDOC TGL THAR TXN ULY USNA VICR YOSH